Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Response to statement made by Phoenix

13 Apr 2021 07:00

RNS Number : 2178V
Dignity PLC
13 April 2021
 

Dignity plc (the "Company")

 

Response to statement made by Phoenix UK Fund Limited ("Phoenix") on 12 April 2021 

 

The independent directors of the Company (the "Independent Directors") note the most recent statement by Phoenix published on its website on 12 April 2021. They note, in particular, the various comments made by Phoenix regarding potential strategies that may be adopted for the future direction of the group's business.

 

It should come as no surprise that many of the ideas disclosed in Phoenix's most recent letter are amongst those currently being assessed in detail by the Board. In the Company's letter to shareholders dated 29 March 2021, the Independent Directors commented on the fact that the vision and views on strategy of Phoenix and those of the Board were already closely aligned, such that the requisitioned shareholder meeting was wholly unnecessary. The Board is well-advanced in its detailed planning towards the announcement of a fully thought-through strategy plan, including the possibility of a distribution of the Crematoria business to existing shareholders on a pro rata basis. It was always intended that the Board would announce its vision for the Company at the time of the Company's AGM in June 2021 and this has been indicated to the market for some time.

 

The Independent Directors find the statements made by Phoenix relating to possible strategies (and public reference to unverified valuations for the Crematoria division, in particular) to be deeply irresponsible. There are significant nuances to any strategic plan of this nature before it can be made public. The interests of all stakeholders need to be carefully addressed including, in this instance, the interests of bondholders and employees, as well as shareholders. There also needs to be a full and complete understanding of all potential regulatory aspects, so that the Board can be sure of its capacity to deliver any publicly announced strategy before it is announced. The Board has already indicated that it is well-aware of the potential value of different elements of the business on a stand-alone basis and of course a core objective is to unlock value for the benefit of all shareholders. However, it is inappropriate to hypothesize on strategies until there is sufficient confidence in a methodology to deliver the same. That Phoenix has chosen to "go public" on these matters prematurely serves only as a further illustration of the lack of suitability of Gary Channon to be appointed as someone responsible for the executive function of the Company.

 

Not for the first time since the Board convened the General Meeting to consider the resolutions proposed, Phoenix has made ill-advised public statements which have been self-serving and have had little regard for the wider interests of shareholders and other stakeholders. The Board has been informed by proxy voting agents, ISS, Glass Lewis and PIRC, that they are advising their members to support the Board and vote against both resolutions at the forthcoming General Meeting. In light of Phoenix's most recent statements, the Independent Directors are more convinced than ever that it is in the best interests of shareholders to allow the current management team to finish its work without handing executive control to Phoenix.

 

The Independent Directors have no hesitation in repeating their recommendation that shareholders should vote AGAINST the resolutions.

 

The Independent Directors of Dignity plc

Gillian Kent, Dean Moore and Paul Humphreys

 

 

Chris Lane

Tilly Abraham

Buchanan +44 (0)20 7466 5000

www.buchanan.uk.com Dignity@buchanan.uk.com

 

13 April 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPGPUCUCUPGPGP
Date   Source Headline
16th Jul 202010:00 amRNSNotice of Interim Results
15th Jun 20205:11 pmRNSDirector Dealing Notification
12th Jun 202012:07 pmRNSDirector Dealing Notification
11th Jun 20202:40 pmRNSBoard Appointment
11th Jun 20202:11 pmRNSResults of AGM
22nd May 202010:51 amRNSDirector Dealing Notification
19th May 20202:07 pmRNSNotification of Major Holdings
11th May 20207:00 amRNSCOVID-19 update
7th May 202012:46 pmRNSVoting Rights and Capital
7th May 202010:00 amRNSChange in Director’s Particulars
22nd Apr 202010:23 amRNSNotification of Major Holdings
17th Apr 20207:00 amRNSAnnual Report and Notice of AGM
14th Apr 202011:35 amRNSBlock Listing 6 Monthly Return
9th Apr 20202:45 pmRNSNotification of Major Holdings
6th Apr 20207:00 amRNSDirector Dealing Notification
6th Apr 20207:00 amRNSDirector Dealing Notification
3rd Apr 202011:27 amRNSMarket update, Board and Broker changes
18th Mar 20207:00 amRNSNotification of Major Holdings
12th Mar 20209:35 amRNSNOTIFICATION OF MAJOR HOLDINGS
11th Mar 20207:00 amRNSBoard Appointment
11th Mar 20207:00 amRNSPreliminary Results
24th Feb 20208:43 amRNSNOTIFICATION OF MAJOR HOLDINGS
11th Feb 20207:00 amRNSNotification of Preliminary Results
6th Feb 202012:07 pmRNSSecond Price Monitoring Extn
6th Feb 202012:02 pmRNSPrice Monitoring Extension
9th Dec 20198:53 amRNSDirectorate Change
6th Dec 20194:40 pmRNSSecond Price Monitoring Extn
6th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Nov 20197:00 amRNSThird quarter trading update
1st Nov 20197:00 amRNSNotification of Q3 Trading Update
15th Oct 20192:33 pmRNSBLOCK LISTING SIX MONTHLY RETURN
27th Sep 20197:00 amRNSAppointment of Chairman
18th Sep 20194:15 pmRNSDirectorate Change
1st Aug 20193:54 pmRNSNOTIFICATION OF MAJOR HOLDINGS
31st Jul 20197:00 amRNSInterim Results
20th Jun 20197:00 amRNSNotification of Interim Results
14th Jun 20199:22 amRNSDirector/PDMR Shareholding
14th Jun 20199:21 amRNSDirector/PDMR Shareholding
14th Jun 20199:20 amRNSDirector/PDMR Shareholding
14th Jun 20199:19 amRNSResults of AGM
3rd Jun 20197:00 amRNSDignity Welcomes HM Treasury proposals
31st May 20198:00 amRNSVoting Rights and Capital
21st May 20192:23 pmRNSNOTIFICATION OF MAJOR HOLDINGS
13th May 20197:00 amRNSFirst quarter trading update
2nd May 20197:00 amRNSDirectorate Changes
15th Apr 20197:00 amRNSNotification of Q1 Trading Update
11th Apr 20193:17 pmRNSAdditional Listing
4th Apr 20191:28 pmRNSNotification of Major Holdings
28th Mar 20192:54 pmRNSNotification of Major Holdings
28th Mar 20197:10 amRNSStatement re: CMA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.